- Home
- BDSX vs MYPS Comparison
BDSX vs MYPS Comparison
Compare BDSX & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- MYPS
- Stock Information
- Founded
- BDSX 2005
- MYPS 2011
- Country
- BDSX United States
- MYPS United States
- Employees
- BDSX N/A
- MYPS N/A
- Industry
- BDSX Precision Instruments
- MYPS EDP Services
- Sector
- BDSX Health Care
- MYPS Technology
- Exchange
- BDSX Nasdaq
- MYPS Nasdaq
- Market Cap
- BDSX 200.0M
- MYPS 175.1M
- IPO Year
- BDSX 2020
- MYPS N/A
- Fundamental
- Price
- BDSX $1.20
- MYPS $1.85
- Analyst Decision
- BDSX Strong Buy
- MYPS Buy
- Analyst Count
- BDSX 4
- MYPS 4
- Target Price
- BDSX $3.08
- MYPS $3.17
- AVG Volume (30 Days)
- BDSX 732.5K
- MYPS 263.7K
- Earning Date
- BDSX 11-01-2024
- MYPS 11-04-2024
- Dividend Yield
- BDSX N/A
- MYPS N/A
- EPS Growth
- BDSX N/A
- MYPS N/A
- EPS
- BDSX N/A
- MYPS N/A
- Revenue
- BDSX $65,562,000.00
- MYPS $298,759,000.00
- Revenue This Year
- BDSX $46.97
- MYPS N/A
- Revenue Next Year
- BDSX $30.43
- MYPS N/A
- P/E Ratio
- BDSX N/A
- MYPS N/A
- Revenue Growth
- BDSX 48.92
- MYPS N/A
- 52 Week Low
- BDSX $1.11
- MYPS $1.20
- 52 Week High
- BDSX $2.21
- MYPS $3.04
- Technical
- Relative Strength Index (RSI)
- BDSX 28.77
- MYPS 67.88
- Support Level
- BDSX $1.11
- MYPS $1.59
- Resistance Level
- BDSX $1.45
- MYPS $1.84
- Average True Range (ATR)
- BDSX 0.09
- MYPS 0.14
- MACD
- BDSX -0.02
- MYPS 0.03
- Stochastic Oscillator
- BDSX 24.32
- MYPS 98.50
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore, and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.